Cargando…

The role of p53 in cancer drug resistance and targeted chemotherapy

Cancer has long been a grievous disease complicated by innumerable players aggravating its cure. Many clinical studies demonstrated the prognostic relevance of the tumor suppressor protein p53 for many human tumor types. Overexpression of mutated p53 with reduced or abolished function is often conne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hientz, Karin, Mohr, André, Bhakta-Guha, Dipita, Efferth, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352454/ https://www.ncbi.nlm.nih.gov/pubmed/27888811 http://dx.doi.org/10.18632/oncotarget.13475

Ejemplares similares

Hormesis: Decoding Two Sides of the Same Coin
por: Bhakta-Guha, Dipita, et al.
Publicado: (2015)

Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion
por: Kadioglu, Onat, et al.
Publicado: (2021)

Epigenetic Alterations Upstream and Downstream of p53 Signaling in Colorectal Carcinoma
por: Tomicic, Maja T., et al.
Publicado: (2021)

Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance
por: Xu, Jingwen, et al.
Publicado: (2020)

Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
por: Volm, Manfred, et al.
Publicado: (2015)

Role of p53 in breast cancer progression: An insight into p53 targeted therapy
por: Marvalim, Charlie, et al.
Publicado: (2023)

RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer
por: Huang, Yuan, et al.
Publicado: (2023)

Role of p53 Serine 46 in p53 Target Gene Regulation
por: Smeenk, Leonie, et al.
Publicado: (2011)

p53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer Cells
por: Ma, Shumei, et al.
Publicado: (2021)

Drugging p53 in cancer: one protein, many targets
por: Hassin, Ori, et al.
Publicado: (2022)

Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
por: Schmidt, Felix, et al.
Publicado: (2016)

Structural and Drug Targeting Insights on Mutant p53
por: Gomes, Ana Sara, et al.
Publicado: (2021)

Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
por: Kadioglu, Onat, et al.
Publicado: (2018)

p53 Family in Resistance to Targeted Therapy of Melanoma
por: Vlašić, Ignacija, et al.
Publicado: (2022)

In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines
por: Blanco-Luquin, Idoia, et al.
Publicado: (2021)

Targeted chemotherapy overcomes drug resistance in melanoma
por: Yue, Jingyin, et al.
Publicado: (2020)

The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise
por: Puszynski, Krzysztof, et al.
Publicado: (2014)

Role of Sex in the Therapeutic Targeting of p53 Circuitry
por: Mancini, Francesca, et al.
Publicado: (2021)

Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017)

Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations
por: Abdel-Rahman, Wael M, et al.
Publicado: (2017)

Impact of Plastic-Related Compounds on P-Glycoprotein and Breast Cancer Resistance Protein In Vitro
por: Rosellini, Matteo, et al.
Publicado: (2023)

The Role of p53 Signaling in Colorectal Cancer
por: Liebl, Magdalena C., et al.
Publicado: (2021)

Novel Roles for P53 in the Genesis and Targeting of Tetraploid Cancer Cells
por: Davaadelger, Batzaya, et al.
Publicado: (2014)

Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo
por: Wu, Xu, et al.
Publicado: (2021)

Drugging in the absence of p53
por: Aning, Obed Akwasi, et al.
Publicado: (2019)

Correction: The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise
Publicado: (2015)

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
por: Chiang, Ming-Fu, et al.
Publicado: (2013)

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
por: Nishikawa, Shigeto, et al.
Publicado: (2023)

The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas
por: Miyazaki, Makoto, et al.
Publicado: (2018)

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
por: Lee, Chiyun, et al.
Publicado: (2021)

Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research
por: Levine, Arnold J.
Publicado: (2022)

Broad targeting of resistance to apoptosis in cancer
por: Mohammad, Ramzi M., et al.
Publicado: (2015)

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
por: Ferrandina, G, et al.
Publicado: (1999)

The Role of p53 Family in Cancer
por: Zawacka-Pankau, Joanna E.
Publicado: (2022)

Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets
por: Mbaveng, Armelle T., et al.
Publicado: (2017)

The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target
por: Fierabracci, Alessandra, et al.
Publicado: (2016)

G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53
por: Saha, Taniya, et al.
Publicado: (2016)

Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment
por: Hrstka, Roman, et al.
Publicado: (2009)

P53-regulated autophagy and its impact on drug resistance and cell fate
por: Shim, Daeun, et al.
Publicado: (2021)

p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration
por: Pandya, Pinakin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_31eu17ro6rpbb07dlfke7u8sd8